PYC Therapeutics Limited

ASX:PYC.AX

0.19 (AUD) • At close November 4, 2024
Bedrijfsnaam PYC Therapeutics Limited
Symbool PYC.AX
Munteenheid AUD
Prijs 0.19
Beurswaarde 849,676,200
Dividendpercentage 0%
52-weken bereik 0.056 - 0.21
Industrie Biotechnology
Sector Healthcare
CEO Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)
Website https://pyctx.com

An error occurred while fetching data.

Over PYC Therapeutics Limited

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic

Vergelijkbare Aandelen

AnteoTech Limited logo

AnteoTech Limited

ADO.AX

0.027 AUD

Paragon Care Limited logo

Paragon Care Limited

PGC.AX

0.42 AUD

Anteris Technologies Ltd logo

Anteris Technologies Ltd

AVR.AX

10.21 AUD

Healthia Limited logo

Healthia Limited

HLA.AX

1.795 AUD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

AVH.AX

3.07 AUD

Medical Developments International Limited logo

Medical Developments International Limited

MVP.AX

0.47 AUD

Probiotec Limited logo

Probiotec Limited

PBP.AX

2.98 AUD

Volpara Health Technologies Limited logo

Volpara Health Technologies Limited

VHT.AX

1.145 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.1 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)